JPS6134426B2 - - Google Patents
Info
- Publication number
- JPS6134426B2 JPS6134426B2 JP52059295A JP5929577A JPS6134426B2 JP S6134426 B2 JPS6134426 B2 JP S6134426B2 JP 52059295 A JP52059295 A JP 52059295A JP 5929577 A JP5929577 A JP 5929577A JP S6134426 B2 JPS6134426 B2 JP S6134426B2
- Authority
- JP
- Japan
- Prior art keywords
- cis
- trans
- methyl
- compounds
- hexahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL7605526A NL7605526A (nl) | 1976-05-24 | 1976-05-24 | Nieuwe tetracyclische derivaten. |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS532465A JPS532465A (en) | 1978-01-11 |
JPS6134426B2 true JPS6134426B2 (en:Method) | 1986-08-07 |
Family
ID=19826245
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5929577A Granted JPS532465A (en) | 1976-05-24 | 1977-05-20 | Novel tetracyclic derivative* its preparation and formulations containing same |
JP61007790A Granted JPS61178965A (ja) | 1976-05-24 | 1986-01-17 | 新規な四環式誘導体 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61007790A Granted JPS61178965A (ja) | 1976-05-24 | 1986-01-17 | 新規な四環式誘導体 |
Country Status (18)
Country | Link |
---|---|
US (1) | US4145434A (en:Method) |
JP (2) | JPS532465A (en:Method) |
AU (1) | AU509073B2 (en:Method) |
BE (1) | BE854915A (en:Method) |
CA (1) | CA1122976A (en:Method) |
CH (2) | CH633536A5 (en:Method) |
DE (2) | DE2723209A1 (en:Method) |
DK (1) | DK157868C (en:Method) |
ES (3) | ES459024A1 (en:Method) |
FI (1) | FI65238C (en:Method) |
FR (1) | FR2352800A1 (en:Method) |
GB (1) | GB1567862A (en:Method) |
HU (1) | HU173795B (en:Method) |
IE (1) | IE45419B1 (en:Method) |
LU (1) | LU77387A1 (en:Method) |
NL (1) | NL7605526A (en:Method) |
SE (1) | SE436202B (en:Method) |
ZA (1) | ZA772752B (en:Method) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0007450A1 (de) * | 1978-07-07 | 1980-02-06 | Ciba-Geigy Ag | Azatetracyclische Carbonitrile, ihre Herstellung, pharmazeutische Präparate, die diese enthalten und deren Verwendung |
DE3069086D1 (de) * | 1979-12-10 | 1984-10-04 | Ciba Geigy Ag | Azatetracyclic carbonitriles |
FR2504140A1 (fr) * | 1981-04-16 | 1982-10-22 | Centre Nat Rech Scient | Nouveaux derives tetracycliques de la dibenzazepine, leur procede de preparation et les compositions pharmaceutiques en renfermant |
IL68711A (en) * | 1982-05-18 | 1986-12-31 | Sparamedica Ag | Dihydro-8-halo-6-phenylpyrrolo-(3,4-d)(2)benzazepin derivatives,their preparation and pharmaceutical compositions containing them |
JPS62101941U (en:Method) * | 1985-12-16 | 1987-06-29 | ||
IE62754B1 (en) * | 1988-08-26 | 1995-02-22 | Akzo Nv | Tetracyclic antidepressants |
EP0569096A1 (en) * | 1992-05-08 | 1993-11-10 | Akzo Nobel N.V. | Depot preparation |
PT690863E (pt) * | 1993-04-06 | 2003-07-31 | Abbott Lab | Compostos tetraciclicos como agonistas da dopamina |
PL180465B1 (pl) * | 1994-03-02 | 2001-02-28 | Akzo Nobel Nv | Kompozycja farmaceutyczna zawierajaca trans-5-chloro-2-metylo-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-c]pirol PL PL PL |
JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
HUP9901613A3 (en) * | 1996-04-12 | 2001-08-28 | Janssen Pharmaceutica Nv | Substituted tetracyclic fused furanamine derivatives, process for their preparation, use thereof and pharmaceutical compositions containing them |
CA2290070A1 (en) * | 1997-05-26 | 1998-12-03 | Akzo Nobel Nv | Salts of aromatic sulphonic acids |
HRP20020305A8 (en) * | 2002-04-10 | 2009-03-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
HRP20020441A2 (en) * | 2002-05-21 | 2003-12-31 | Pliva D D | 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof |
HRP20030160A2 (en) * | 2003-03-06 | 2005-04-30 | Pliva-Istra�iva�ki institut d.o.o. | 1-thiadibenzoazulene derivatives and biological action thereof |
KR20060011873A (ko) * | 2003-05-16 | 2006-02-03 | 화이자 프로덕츠 인코포레이티드 | 비정형 항정신약과 gaba 조절제, 항경련성 약물 또는 벤조다이아제핀의 치료 혼합물 |
HRP20030885A2 (en) * | 2003-11-03 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS |
HRP20030958A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1,3-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
HRP20030953A2 (en) * | 2003-11-21 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
HRP20030956A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU |
HRP20030954A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva D.D. | USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
HRP20030955A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
HRP20030957A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
HRP20030959A2 (en:Method) * | 2003-11-21 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | |
HRP20040104A2 (en) * | 2004-01-30 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
CA2556160A1 (en) * | 2004-02-13 | 2005-09-01 | Pfizer Products Inc. | Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists |
EP1753460A2 (en) * | 2004-05-11 | 2007-02-21 | Pfizer Products Inc. | Combination of atypical antipsychotics and 5-ht1b receptor antagonists |
BRPI0516000A (pt) * | 2004-10-15 | 2008-05-06 | Pfizer | uso de um composto ou de um sal, solvato, hidrato ou isÈmero óptico farmaceuticamente aceitável do mesmo, método para tratar distúrbio bipolar em um mamìfero em necessidade do mesmo, e, kit para uso no tratamento de distúrbios bipolares |
US7872147B2 (en) | 2005-04-07 | 2011-01-18 | N. V. Organon | Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole |
UA93043C2 (ru) | 2005-04-07 | 2011-01-10 | Н.В. Органон | ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ ДЛЯ ПОЛУЧЕНИЯ ТРАНС-5-ХЛОР-2-МЕТИЛ-2,3,3А,12В-ТЕТРАГИДРО-1Н-ДИБЕНЗ[2,3:6,7]ОКСЕПИНО[4,5-с]ПИРОЛА |
PL1917267T3 (pl) * | 2005-04-07 | 2009-06-30 | Merck Sharp & Dohme | Postać krystaliczna maleinianu asenapiny |
US7741358B2 (en) * | 2005-04-14 | 2010-06-22 | N.V. Organon | Crystal form of asenapine maleate |
WO2007046554A1 (ja) * | 2005-10-21 | 2007-04-26 | Sumitomo Chemical Company, Limited | ジベンゾオキセピノピロール化合物の製造方法、その中間体及び該中間体の製造方法 |
US7750167B2 (en) * | 2006-07-05 | 2010-07-06 | N.V. Organon | Process for the preparation of asenapine and intermediate products used in said process |
TW200817414A (en) * | 2006-07-05 | 2008-04-16 | Organon Nv | Process for the preparation of asenapine and intermediate products used in said process |
PE20081457A1 (es) * | 2006-10-06 | 2008-10-18 | Organon Nv | Asenapina amorfa, procesos para prepararlas y su uso para tratar trastornos del sistema nervioso central |
US7875729B2 (en) * | 2007-01-05 | 2011-01-25 | Synthon Bv | Process for making asenapine |
EP2170399A1 (en) * | 2007-06-05 | 2010-04-07 | Synthon B.V. | Intranasal administration of asenapine and pharmaceutical compositions therefor |
JP5245428B2 (ja) * | 2007-07-06 | 2013-07-24 | 住友化学株式会社 | トランス−ジベンゾオキセノピロール化合物の製造方法およびその中間体 |
MX2010007404A (es) * | 2008-01-04 | 2010-10-05 | Organon Nv | Procedimiento para la preparacion de asenapina y productos intermediarios utilizados en dicho procedimiento. |
EP2254420A4 (en) | 2008-02-20 | 2012-02-15 | Targia Pharmaceuticals | CNS PHARMACEUTICALS AND METHOD FOR THEIR USE |
JP2011526881A (ja) * | 2008-06-25 | 2011-10-20 | ファイザー・インク | ジアリール化合物およびそれらの使用 |
JP5801295B2 (ja) | 2009-06-24 | 2015-10-28 | メルク・シャープ・エンド・ドーム・ベー・フェー | アセナピンを含有する注射可能な配合物およびそれを用いた処置方法 |
AR077429A1 (es) | 2009-07-29 | 2011-08-24 | Organon Nv | Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos |
CA2802990A1 (en) | 2010-06-18 | 2011-12-22 | Dr. Reddy's Laboratories Ltd. | Asenapine maleate |
WO2012013766A1 (en) | 2010-07-29 | 2012-02-02 | Laboratorios Lesvi, S.L. | Novel process for the preparation of asenapine |
CA2818025A1 (en) | 2010-11-15 | 2012-05-24 | Agenebio, Inc. | Pyridazine derivatives, compositions and methods for treating cognitive impairment |
WO2012066565A2 (en) | 2010-11-16 | 2012-05-24 | Cadila Healthcare Limited | Asenapine maleate amorphous and crystalline form and process for preparation thereof |
EP2468750A1 (en) | 2010-12-13 | 2012-06-27 | Chemo Ibérica, S.A. | Polymorphic forms of asenapine maleate and processes for their preparation |
ES2575544T3 (es) | 2010-12-24 | 2016-06-29 | Medichem, S.A. | Procedimientos para la preparación de 5-cloro-2-metil-2,3,3a,12b-tetrahidro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pirrol |
WO2012123325A1 (en) | 2011-03-11 | 2012-09-20 | Medichem S.A. | NEW CRYSTAL FORMS OF THE SALT OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE WITH MALEIC ACID |
ITMI20110734A1 (it) | 2011-05-02 | 2012-11-03 | Olon Spa | Sali cristallini di asenapina |
EP2524921A1 (en) * | 2011-05-17 | 2012-11-21 | Sandoz AG | Novel Crystalline Salts of Asenapine |
EP2524919A1 (en) * | 2011-05-17 | 2012-11-21 | Sandoz AG | Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids |
WO2012156676A1 (en) | 2011-05-18 | 2012-11-22 | Laboratorios Lesvi S.L. | Monoclinic crystalline form of asenapine maleate with a specific particle size distribution |
JP6014656B2 (ja) | 2011-05-18 | 2016-10-25 | ラビラトリオス レスビ エス エレ | 化合物の多形体 |
WO2013024492A2 (en) | 2011-07-01 | 2013-02-21 | Megafine Pharma (P) Ltd. | A process for the preparation of asenapine and novel salts thereof |
US9145421B2 (en) | 2011-07-20 | 2015-09-29 | Ranbaxy Laboratories Limited | Process for the preparation of asenapine maleate |
WO2013035109A1 (en) | 2011-09-08 | 2013-03-14 | Mylan Laboratories Ltd | Improved process for the preparation of asenapine maleate |
WO2013041604A1 (en) | 2011-09-21 | 2013-03-28 | Sandoz Ag | Crystal form of asenapine maleate |
EP2572703A1 (en) | 2011-09-21 | 2013-03-27 | Hexal AG | Compressed oral dosage form for asenapine maleate |
AU2012346880A1 (en) | 2011-11-28 | 2014-06-19 | Sun Pharmaceutical Industries Limited | Process for the preparation of asenapine intermediate |
CN103254201B (zh) * | 2012-02-21 | 2016-04-13 | 四川科伦药物研究有限公司 | 一种阿塞那平的制备方法 |
WO2013190481A1 (en) * | 2012-06-21 | 2013-12-27 | Alembic Pharmaceuticals Limited | Process for preparing asenapine and salts of intermediates thereof |
ITMI20121810A1 (it) | 2012-10-24 | 2014-04-25 | Chemo Iberica Sa | Poliformi di maleato di asenapina e processo per la loro preparazione |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
WO2014127786A1 (en) | 2013-02-22 | 2014-08-28 | Zentiva, K.S. | Orally disintegrating pharmaceutical composition comprising asenapine |
CN103113379A (zh) * | 2013-03-12 | 2013-05-22 | 盛世泰科生物医药技术(苏州)有限公司 | 阿塞那平马来酸盐的合成工艺 |
CN103351393B (zh) * | 2013-07-03 | 2016-04-06 | 华裕(无锡)制药有限公司 | 用于制备阿森那平之还原剂及阿森那平之制备方法 |
CA3123897C (en) | 2013-12-20 | 2024-02-06 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
CN103772400A (zh) * | 2014-01-07 | 2014-05-07 | 万特制药(海南)有限公司 | 反式-5-氯-2,3,3a,12b-四氢-1H-二苯并[2,3:6,7]氧杂卓并[4,5-c]吡咯的制备方法 |
CN103772401A (zh) * | 2014-01-07 | 2014-05-07 | 万特制药(海南)有限公司 | 11-氯-2,3,3a,12b-四氢-2-甲基-1H-二苯并[2,3:6,7]氧杂卓并[4,5-c]吡咯-1-酮的一种新精制方法 |
US11154510B2 (en) | 2015-06-11 | 2021-10-26 | Alrise Biosystems Gmbh | Process for the preparation of drug loaded microparticles |
AU2016279052A1 (en) | 2015-06-19 | 2018-02-15 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
BR112019012821A2 (pt) | 2016-12-19 | 2019-11-26 | Agenebio Inc | derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo |
US20180170941A1 (en) | 2016-12-19 | 2018-06-21 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
WO2018115010A1 (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
CN115813887A (zh) | 2016-12-20 | 2023-03-21 | 罗曼治疗系统股份公司 | 包含阿塞那平的透皮治疗系统 |
ES2881783T3 (es) | 2017-06-26 | 2021-11-30 | Lts Lohmann Therapie Systeme Ag | Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona |
WO2019246300A1 (en) | 2018-06-19 | 2019-12-26 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
BR112020026099A2 (pt) | 2018-06-20 | 2021-03-23 | Lts Lohmann Therapie-Systeme Ag | sistema terapêutico transdérmico que contém asenapina |
EP3810099A1 (en) | 2018-06-20 | 2021-04-28 | LTS Lohmann Therapie-Systeme AG | Transdermal therapeutic system containing asenapine |
CN110183457A (zh) * | 2019-06-27 | 2019-08-30 | 浙江天顺药业有限公司 | 一种阿塞那平及其制备方法 |
CN112830931A (zh) | 2019-08-13 | 2021-05-25 | 浙江奥翔药业股份有限公司 | 制备阿塞那平的方法 |
US11679407B2 (en) * | 2020-06-26 | 2023-06-20 | Intel Corporation | Liquid metal thermal interface material application |
WO2023006954A1 (en) | 2021-07-30 | 2023-02-02 | Fundació Institut D'investigació Biomèdica De Bellvitge (Idibell) | Asenapine for use in cancer |
JP2025529834A (ja) | 2022-08-19 | 2025-09-09 | エージンバイオ, インコーポレイテッド | 認知障害を処置するためのベンゾアゼピン誘導体、組成物および方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH507232A (de) * | 1968-11-27 | 1971-05-15 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Thiepin- und Oxepinderivaten |
NL178593C (nl) * | 1974-01-31 | 1986-04-16 | Akzo Nv | Werkwijze ter bereiding van een farmaceutisch preparaat op basis van een tetracyclische verbinding en werkwijze voor de bereiding van de daarbij te gebruiken tetracyclische verbindingen. |
AU469026B2 (en) * | 1974-11-07 | 1976-01-29 | Ciba-Geigy Ag | New azepine derivatives and process forthe production thereof |
-
1976
- 1976-05-24 NL NL7605526A patent/NL7605526A/xx not_active Application Discontinuation
-
1977
- 1977-05-09 ZA ZA00772752A patent/ZA772752B/xx unknown
- 1977-05-13 GB GB20275/77A patent/GB1567862A/en not_active Expired
- 1977-05-17 IE IE1013/77A patent/IE45419B1/en not_active IP Right Cessation
- 1977-05-18 US US05/798,222 patent/US4145434A/en not_active Expired - Lifetime
- 1977-05-18 FR FR7715413A patent/FR2352800A1/fr active Granted
- 1977-05-20 CH CH626477A patent/CH633536A5/de not_active IP Right Cessation
- 1977-05-20 AU AU25331/77A patent/AU509073B2/en not_active Expired
- 1977-05-20 JP JP5929577A patent/JPS532465A/ja active Granted
- 1977-05-20 SE SE7705957A patent/SE436202B/xx not_active IP Right Cessation
- 1977-05-21 ES ES459024A patent/ES459024A1/es not_active Expired
- 1977-05-23 DE DE19772723209 patent/DE2723209A1/de not_active Withdrawn
- 1977-05-23 HU HU77AO447A patent/HU173795B/hu unknown
- 1977-05-23 FI FI771635A patent/FI65238C/fi not_active IP Right Cessation
- 1977-05-23 LU LU77387A patent/LU77387A1/xx unknown
- 1977-05-23 BE BE177807A patent/BE854915A/xx not_active IP Right Cessation
- 1977-05-23 DE DE2760372A patent/DE2760372C2/de not_active Expired - Lifetime
- 1977-05-24 DK DK227477A patent/DK157868C/da not_active IP Right Cessation
- 1977-05-24 CA CA279,010A patent/CA1122976A/en not_active Expired
-
1978
- 1978-06-01 ES ES470408A patent/ES470408A1/es not_active Expired
- 1978-06-01 ES ES470407A patent/ES470407A1/es not_active Expired
-
1982
- 1982-06-07 CH CH351282A patent/CH637382A5/de not_active IP Right Cessation
-
1986
- 1986-01-17 JP JP61007790A patent/JPS61178965A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
LU77387A1 (en:Method) | 1977-08-29 |
ZA772752B (en) | 1978-04-26 |
CH637382A5 (de) | 1983-07-29 |
FI65238C (fi) | 1984-04-10 |
DE2760372C2 (en:Method) | 1991-05-29 |
DE2723209A1 (de) | 1977-12-15 |
DK157868B (da) | 1990-02-26 |
HU173795B (hu) | 1979-08-28 |
JPS6238348B2 (en:Method) | 1987-08-17 |
JPS61178965A (ja) | 1986-08-11 |
DK157868C (da) | 1990-07-30 |
BE854915A (fr) | 1977-11-23 |
SE436202B (sv) | 1984-11-19 |
AU509073B2 (en) | 1980-04-17 |
FI771635A7 (en:Method) | 1977-11-25 |
JPS532465A (en) | 1978-01-11 |
IE45419L (en) | 1977-11-24 |
SE7705957L (sv) | 1977-11-25 |
CH633536A5 (de) | 1982-12-15 |
ES470408A1 (es) | 1979-01-01 |
AU2533177A (en) | 1978-11-23 |
FI65238B (fi) | 1983-12-30 |
FR2352800B1 (en:Method) | 1980-02-01 |
NL7605526A (nl) | 1977-11-28 |
FR2352800A1 (fr) | 1977-12-23 |
GB1567862A (en) | 1980-05-21 |
CA1122976A (en) | 1982-05-04 |
US4145434A (en) | 1979-03-20 |
DK227477A (da) | 1977-11-25 |
ES470407A1 (es) | 1979-01-01 |
IE45419B1 (en) | 1982-08-25 |
ES459024A1 (es) | 1978-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6134426B2 (en:Method) | ||
CA1076571A (en) | Tetracyclic derivatives of benzo-pyrido azepines | |
CS221288B2 (en) | Method of making the heterocyclic compounds | |
CA1306251C (en) | Psychotropic polycyclic imides | |
JPS623153B2 (en:Method) | ||
EP0033767B1 (en) | Indolobenzoxazines, processes for preparing and pharmaceutical compositions containing the same | |
US4362739A (en) | Pyrrolo(2,3-d)carbazole derivatives, compositions and use | |
JP2521157B2 (ja) | 四環式抗うつ剤 | |
US4271179A (en) | 1,2,3,3a,8,12b-Hexahydro-dibenzo[1,2;5,6]cyclohepta[3,4-C]pyrroles and pharmaceutical use thereof | |
US4158059A (en) | Tension reducing 2,3,4,4a,9,136-hexahydro-dibenz[1,2;5,6]cyclohepta[3,4-c]py | |
CS207619B2 (en) | Method of making the new derivatives of 5,11-dihydro-6h-pyrido 2,3-b 1,4 benzodiazepin-6-on | |
KR100392060B1 (ko) | 5-ht2수용체에대한친화성을가진치환된테트라사이클릭아제핀유도체 | |
HUT71488A (en) | Process for the production of neuroleptic 2-substituted perhydro-1-h-pyrido[1,2a]pyrazines and pharmaceuticals compositions containing the same | |
GB1596170A (en) | 1,2,3,4,4a,10b-hexahydro-benz(f)isouqinolines | |
US3839341A (en) | Substituted 1,3,8-triazaspiro(4.5)decanes | |
US4271177A (en) | 2,3,3a,12b-Tetrahydro-1H-dibenzo[2,3;6,7]thiepino[4,5-c]pyrroles and pharmaceutical use thereof | |
US4859671A (en) | 2-substituted 1,2-benzisothiazol-3(2H)-one 1,1-dioxide useful as an anxiolytic agent | |
US4824999A (en) | Psychotropic polycyclic imides | |
US4177275A (en) | Tension reducing 2,3,4,4a,9,13b-hexahydro-1H-dibenzo[b,f]pyrido[3,4-d]azepine derivatives | |
US4428880A (en) | Azepino[4,5-d]indole derivatives and preparation thereof | |
KR830001667B1 (ko) | 페닐 퀴놀리지딘의 제조방법 | |
HU193937B (en) | Process for preparing hexahydro-pyrrolo/2,1-a/isoquinoline derivatives and pharmaceutics comprising these compounds as active substance | |
JPH085881B2 (ja) | 1,2,3,4―テトラヒドロアクリジンの縮合複素環状誘導体 | |
US4271178A (en) | 1,2,3,3a,8,12b-Hexahydro-dibenzo[b,f]pyrrolo[3,4-d]azepines and pharmaceutical use thereof | |
US3516993A (en) | Benzylidene-substituted nitrogenous heterocyclic compounds |